Baxter Profit Pressures Lead To Expanded Restructuring, SEC Probe
This article was originally published in The Gray Sheet
Executive Summary
Baxter expects to save $120-$160 mil. annually upon completion of a revised restructuring plan that includes the closure of 30 facilities and downsizing its workforce by 6%, or 3,200 employees
You may also be interested in...
Gambro Sale Of U.S. Dialysis Services Leaves $2 Bil. For Possible Acquisitions
Gambro's plan to refocus on its core renal and blood bank product offerings by divesting its U.S. dialysis services business provides about $2 bil. for potential acquisitions in related fields
Gambro Sale Of U.S. Dialysis Services Leaves $2 Bil. For Possible Acquisitions
Gambro's plan to refocus on its core renal and blood bank product offerings by divesting its U.S. dialysis services business provides about $2 bil. for potential acquisitions in related fields
Buck Stops With Kraemer: Baxter CEO Resigns To Restore Investor Confidence
A fresh round of restructuring will save Baxter $200 mil.-$300 mil. a year, shore up core business segments and help pave the way for future growth, the firm says